作者:
Feagan,B.G. [1]
;
Sandborn,W.J. [2]
;
D'Haens,G. [3]
;
Pola,S. [4]
;
McDonald,J.W.D. [5]
;
Rutgeerts,P. [6]
;
Munkholm,P. [7]
;
Mittmann,U. [8]
;
King,D. [9]
;
Wong,C.J. [10]
;
Zou,G. [11]
;
Donner,A. [12]
;
Shackelton,L.M. ;
Gilgen,D. ;
Nelson,S. ;
Vandervoort,M.K. ;
Fahmy,M. ;
LoftusJr.,E.V. ;
Panaccione,R. ;
Travis,S.P. ;
VanAssche,G.A. ;
Vermeire,S. ;
Levesque,B.G.
作者单位:
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
[1]
Robarts West, San Diego, CA, United States
[2]
Mittmann Pharma Consulting, Basel, Switzerland
[3]
Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada
[4]
Department of Gastroenterology, Academic Medical Center, Robarts Europe, Amsterdam, Netherlands
[5]
Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom
[6]
Robarts Clinical Trials, Western University, 100 Perth Drive, London, ON N6A 5K8, Canada
[7]
Digestive Disease Center, Medical Section, Herlev University Hospital, Herlev, Denmark
[8]
Tillotts Pharma AG, Rheinfelden, Switzerland
[9]
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States
[10]
UCSD Inflammatory Bowel Disease Center, University of California San Diego, San Diego, CA, United
[11]
Division of Gastroenterology, Mount Sinai Hospital, Toronto, ON, Canada
[12]
发布时间
2013-11-20